医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

广告
第一作者: James,Yarmolinsky
作者单位: MRC Integrative Epidemiology Unit,University of Bristol [1] Department of Hygiene and Epidemiology,University of Ioannina Medical School [2] Biomarkers and Susceptibility Unit, Oncology Data Analytics Program,Catalan Institute of Oncology [3] Corporal Michael J. Crescenz VA Medical Center [4] VA Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto Health Care [5] Nutrition and Metabolism Section, International Agency for Research on Cancer,World Health [6] Department of Medicine I,University Hospital Dresden, Technische Universit?t Dresden (TU Dresden) [7] University of Texas MD Anderson Cancer Center [8] Department of Public Health and Primary Care,University of Cambridge [9] Department of Medicine and Epidemiology,University of Pittsburgh Medical Center [10] Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital,University of Toronto [11] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health,The [12] Department of Laboratory Medicine and Pathology,Mayo Clinic Arizona [13] Department of Epidemiology and Biostatistics, School of Public Health,Imperial College London, St [14]
发布时间 2023-08-30
提交
  • 浏览0
Diabetologia: Clinical and Experimental Diabetes and Metabolism = Organ of the European Association for the Study of Diabetes (EASD)

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷